Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals... Show more
KYKOF saw its Momentum Indicator move below the 0 level on November 14, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator turned negative. In of the 40 cases, the stock moved further down in the following days. The odds of a decline are at .
KYKOF moved below its 50-day moving average on November 14, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for KYKOF crossed bearishly below the 50-day moving average on November 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.554) is normal, around the industry mean (8.828). P/E Ratio (34.004) is within average values for comparable stocks, (23.985). KYKOF's Projected Growth (PEG Ratio) (4.626) is slightly higher than the industry average of (2.041). Dividend Yield (0.025) settles around the average of (0.027) among similar stocks. P/S Ratio (2.656) is also within normal values, averaging (3.575).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. KYKOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYKOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
Industry PharmaceuticalsMajor
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLYD | 8.54 | 0.21 | +2.51% |
| MicroSectors™ Travel -3X Inv Lvgd ETNs | |||
| PREF | 19.02 | 0.03 | +0.16% |
| Principal Spectrum Pref Secs Actv ETF | |||
| FLTB | 50.73 | 0.04 | +0.08% |
| Fidelity Limited Term Bond ETF | |||
| AIYY | 1.91 | -0.02 | -1.04% |
| YieldMax AI Option Income Strategy ETF | |||
| RGTU | 25.76 | -0.42 | -1.60% |
| Tradr 2X Long RGTI Daily ETF | |||
A.I.dvisor tells us that KYKOF and OPHLY have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYKOF and OPHLY's prices will move in lockstep.
| Ticker / NAME | Correlation To KYKOF | 1D Price Change % | ||
|---|---|---|---|---|
| KYKOF | 100% | N/A | ||
| OPHLY - KYKOF | 12% Poorly correlated | -0.94% | ||
| NVSEF - KYKOF | 7% Poorly correlated | -4.13% | ||
| GIKLY - KYKOF | 4% Poorly correlated | N/A | ||
| MAYNF - KYKOF | -1% Poorly correlated | +17.88% | ||
| HAWPF - KYKOF | -1% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To KYKOF | 1D Price Change % |
|---|---|---|
| KYKOF | 100% | N/A |
| Pharmaceuticals: Major industry (61 stocks) | 1% Poorly correlated | +0.02% |
| Pharmaceuticals industry (378 stocks) | -0% Poorly correlated | -0.45% |